cisplatin and 5-Fu combined with nimotuzumab
PF-N-UMNPC
Phase 2 small_molecule completed
Quick answer
cisplatin and 5-Fu combined with nimotuzumab for Stage IV Nasopharyngeal Carcinoma is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Stage IV Nasopharyngeal Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed